Literature DB >> 26490982

Far upstream element-binding protein 1 (FUBP1) is a potential c-Myc regulator in esophageal squamous cell carcinoma (ESCC) and its expression promotes ESCC progression.

Lei Yang1, Jun-Ya Zhu2, Jian-Guo Zhang2, Bo-Jun Bao2, Cheng-Qi Guan2, Xiao-Jing Yang1, Yan-Hua Liu2, Yue-Jiao Huang1, Run-Zhou Ni3, Li-Li Ji4.   

Abstract

The human far upstream element (FUSE) binding protein 1 (FUBP1) belongs to an ancient family which is required for proper regulation of the c-Myc proto-oncogene. Although c-Myc plays an important role in development of various carcinomas, the relevance of FUBP1 and their contribution to esophageal squamous cell carcinoma (ESCC) development remain unclear. In this study, we aimed to investigate the relationship between FUBP1 and c-Myc as well as their contribution to ESCC development. Western blot and immunohistochemical analyses were performed to evaluate FUBP1 expression. Coimmunoprecipitation analysis was performed to explore the correlation between FUBP1 and c-Myc in ESCC. In addition, the role of FUBP1 in ESCC proliferation was studied in ESCC cells through knocking FUBP1 down. The regulation of FUBP1 on proliferation was confirmed by Cell Counting Kit-8 (CCK-8) assay, flow cytometric assays, and clone formation assays. The expressions of FUBP1 and c-Myc were both upregulated in ESCC tissues. In addition to correlation between expression of FUBP1 and tumor grade, we also confirmed the correlation of FUBP1, c-Myc, and Ki-67 expression by twos. Moreover, upregulation of FUBP1 and c-Myc in ESCC was associated with poor survival. FUBP1 was confirmed to activate c-Myc in ESCC tissues and cells. FUBP1 was demonstrated to promote proliferation of ESCC cells. Moreover, downregulation of both FUBP1 and c-Myc was confirmed to inhibit proliferation of ESCC cells. Our results indicated that FUBP1 may potentially stimulate c-Myc expression in ESCC and its expression may promote ESCC progression.

Entities:  

Keywords:  Esophageal squamous cell carcinoma (ESCC); FUBP1; Proliferation; c-Myc

Mesh:

Substances:

Year:  2015        PMID: 26490982     DOI: 10.1007/s13277-015-4263-8

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  25 in total

1.  A far upstream element stimulates c-myc expression in undifferentiated leukemia cells.

Authors:  M I Avigan; B Strober; D Levens
Journal:  J Biol Chem       Date:  1990-10-25       Impact factor: 5.157

2.  FUSE binding protein 1 interacts with untranslated regions of Japanese encephalitis virus RNA and negatively regulates viral replication.

Authors:  Hsu-Ling Chien; Ching-Len Liao; Yi-Ling Lin
Journal:  J Virol       Date:  2011-03-02       Impact factor: 5.103

3.  Complete regression of established murine hepatocellular carcinoma by in vivo tumor necrosis factor alpha gene transfer.

Authors:  G Cao; S Kuriyama; P Du; T Sakamoto; X Kong; K Masui; Z Qi
Journal:  Gastroenterology       Date:  1997-02       Impact factor: 22.682

4.  Loss of FBP1 by Snail-mediated repression provides metabolic advantages in basal-like breast cancer.

Authors:  Chenfang Dong; Tingting Yuan; Yadi Wu; Yifan Wang; Teresa W M Fan; Sumitra Miriyala; Yiwei Lin; Jun Yao; Jian Shi; Tiebang Kang; Pawel Lorkiewicz; Daret St Clair; Mien-Chie Hung; B Mark Evers; Binhua P Zhou
Journal:  Cancer Cell       Date:  2013-02-28       Impact factor: 31.743

5.  A sequence-specific, single-strand binding protein activates the far upstream element of c-myc and defines a new DNA-binding motif.

Authors:  R Duncan; L Bazar; G Michelotti; T Tomonaga; H Krutzsch; M Avigan; D Levens
Journal:  Genes Dev       Date:  1994-02-15       Impact factor: 11.361

Review 6.  Far upstream element binding protein 1: a commander of transcription, translation and beyond.

Authors:  J Zhang; Q M Chen
Journal:  Oncogene       Date:  2012-08-27       Impact factor: 9.867

7.  Expression of far upstream element (FUSE) binding protein 1 in human glioma is correlated with c-Myc and cell proliferation.

Authors:  Zongmei Ding; Xiancheng Liu; Yonghua Liu; Jianguo Zhang; Xianting Huang; Xiaojing Yang; Li Yao; Gang Cui; Donglin Wang
Journal:  Mol Carcinog       Date:  2013-12-17       Impact factor: 4.784

Review 8.  Death receptors as targets of cancer therapeutics.

Authors:  M Saeed Sheikh; Ying Huang
Journal:  Curr Cancer Drug Targets       Date:  2004-02       Impact factor: 3.428

9.  Overexpression of far upstream element binding proteins: a mechanism regulating proliferation and migration in liver cancer cells.

Authors:  Mona Malz; Achim Weber; Stephan Singer; Vera Riehmer; Michaela Bissinger; Marc-Oliver Riener; Thomas Longerich; Christopher Soll; Arndt Vogel; Peter Angel; Peter Schirmacher; Kai Breuhahn
Journal:  Hepatology       Date:  2009-10       Impact factor: 17.425

10.  Coordinated expression of stathmin family members by far upstream sequence element-binding protein-1 increases motility in non-small cell lung cancer.

Authors:  Stephan Singer; Mona Malz; Esther Herpel; Arne Warth; Michaela Bissinger; Martina Keith; Thomas Muley; Michael Meister; Hans Hoffmann; Roland Penzel; Georg Gdynia; Volker Ehemann; Philipp Albert Schnabel; Ruprecht Kuner; Peter Huber; Peter Schirmacher; Kai Breuhahn
Journal:  Cancer Res       Date:  2009-03-03       Impact factor: 12.701

View more
  12 in total

1.  MiR-16-1 Targeted Silences Far Upstream Element Binding Protein 1 to Advance the Chemosensitivity to Adriamycin in Gastric Cancer.

Authors:  Danyi Zhao; Yang Zhang; Lei Song
Journal:  Pathol Oncol Res       Date:  2017-06-30       Impact factor: 3.201

Review 2.  The master regulator FUBP1: its emerging role in normal cell function and malignant development.

Authors:  Lydie Debaize; Marie-Bérengère Troadec
Journal:  Cell Mol Life Sci       Date:  2018-10-20       Impact factor: 9.261

3.  Disturbed alternative splicing of FIR (PUF60) directed cyclin E overexpression in esophageal cancers.

Authors:  Yukiko Ogura; Tyuji Hoshino; Nobuko Tanaka; Guzhanuer Ailiken; Sohei Kobayashi; Kouichi Kitamura; Bahityar Rahmutulla; Masayuki Kano; Kentarou Murakami; Yasunori Akutsu; Fumio Nomura; Sakae Itoga; Hisahiro Matsubara; Kazuyuki Matsushita
Journal:  Oncotarget       Date:  2018-05-01

4.  High expression of FUSE binding protein 1 in breast cancer stimulates cell proliferation and diminishes drug sensitivity.

Authors:  Wei Liu; Xifeng Xiong; Weiguang Chen; Xiaojian Li; Xing Hua; Zhihe Liu; Zhi Zhang
Journal:  Int J Oncol       Date:  2020-06-10       Impact factor: 5.650

5.  Interplay between transcription regulators RUNX1 and FUBP1 activates an enhancer of the oncogene c-KIT and amplifies cell proliferation.

Authors:  Lydie Debaize; Hélène Jakobczyk; Stéphane Avner; Jérémie Gaudichon; Anne-Gaëlle Rio; Aurélien A Sérandour; Lena Dorsheimer; Frédéric Chalmel; Jason S Carroll; Martin Zörnig; Michael A Rieger; Olivier Delalande; Gilles Salbert; Marie-Dominique Galibert; Virginie Gandemer; Marie-Bérengère Troadec
Journal:  Nucleic Acids Res       Date:  2018-11-30       Impact factor: 16.971

6.  PUF60 accelerates the progression of breast cancer through downregulation of PTEN expression.

Authors:  Dongying Sun; Wei Lei; Xiaodong Hou; Hui Li; Wenlu Ni
Journal:  Cancer Manag Res       Date:  2019-01-17       Impact factor: 3.989

7.  Identification of key genes and pathways downstream of the β-catenin-TCF7L1 complex in pancreatic cancer cells using bioinformatics analysis.

Authors:  Yi-Hang Yuan; Jian Zhou; Yan Zhang; Meng-Dan Xu; Jing Wu; Wei Li; Meng-Yao Wu; Dao-Ming Li
Journal:  Oncol Lett       Date:  2019-06-06       Impact factor: 2.967

8.  PIDD interaction with KEAP1 as a new mutation-independent mechanism to promote NRF2 stabilization and chemoresistance in NSCLC.

Authors:  Lili Ji; Rui Zhang; Jie Chen; Qun Xue; Nadeem Moghal; Ming-Sound Tsao
Journal:  Sci Rep       Date:  2019-08-27       Impact factor: 4.379

9.  FUBP1 mediates the growth and metastasis through TGFβ/Smad signaling in pancreatic adenocarcinoma.

Authors:  Yue Zhang; Jinlian Chen; Nvshi Zhou; Yun Lu; Jingwen Lu; Xin Xing; Hua Chen; Xingxing Zhang
Journal:  Int J Mol Med       Date:  2021-03-02       Impact factor: 4.101

10.  The circACTN4 interacts with FUBP1 to promote tumorigenesis and progression of breast cancer by regulating the expression of proto-oncogene MYC.

Authors:  Xiaosong Wang; Lei Xing; Rui Yang; Hang Chen; Min Wang; Rong Jiang; Luyu Zhang; Junxia Chen
Journal:  Mol Cancer       Date:  2021-06-11       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.